Compare AstraZeneca plc (AZN) vs Enovix Corporation (ENVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Enovix Corporation — how do they compare? AstraZeneca plc trades at $158.1 (market cap $248.14B), while Enovix Corporation trades at $4.88 (market cap $1.06B). The key difference: AstraZeneca plc is far larger — about 234.1× Enovix Corporation's market cap, and AstraZeneca plc pays a 2.01% dividend while Enovix Corporation pays none. Which is the better fit depends on your goals.
| AZN | ENVX | |
|---|---|---|
Market Cap | $248.14B | $1.06B |
Sector | Health | Technology |
52-Week High | $209.48 | $13.19 |
52-Week Low | $147.06 | $3.68 |
Enterprise Value | $275.41B | $1.07B |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →
